"After admission of insolvency proceedings by NCLT, the stock price has corrected sharply. The next NCLT hearing is due on March 09, 2023, and unless ZEEL settles the dispute amicably or achieves a stay on the order, merger time-line can get delayed further. We retain BUY on the stock with a target price of Rs277 (21x Sep-24 EPS). However, given there are concerns over delay in merger time-line (primary premise of our BUY call) the stock remain under pressure in the near-term," wrote analysts at Prabhudas Lilladher in a note.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)